Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Hold
1,050
0.1% 122
2026
Q1
$199K Hold
1,050
0.1% 114
2025
Q4
$179K Sell
1,050
-200
-16% -$30.7K 0.09% 117
2025
Q3
$165K Hold
1,250
0.09% 115
2025
Q2
$133K Buy
1,250
+100
+9% +$10.9K 0.07% 121
2025
Q1
$143K Hold
1,150
0.09% 115
2024
Q4
$142K Sell
1,150
-100
-8% -$11.8K 0.08% 113
2024
Q3
$139K Buy
1,250
+150
+14% +$16.4K 0.09% 107
2024
Q2
$117K Hold
1,100
0.08% 107
2024
Q1
$132K Buy
1,100
+100
+10% +$12.2K 0.09% 106
2023
Q4
$123K Hold
1,000
0.1% 101
2023
Q3
$123K Buy
1,000
+100
+11% +$13.3K 0.1% 101
2023
Q2
$112K Buy
900
+140
+18% +$18.8K 0.1% 115
2023
Q1
$111K Buy
+760
New +$112K 0.11% 108

Other funds holding JAZZ

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s JAZZ Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 1,050 shares worth $253K. The position accounts for 0.1% of the portfolio, ranked #122.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in JAZZ in Q1 2023 and has held it in 14 quarters since. 449 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 1,050 shares of Jazz Pharmaceuticals worth $253K as of Q2 2026.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.1% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #122 holding.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 449 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.